Tissue response to neural implants: the use of model systems toward new design solutions of implantable microelectrodes

M Gulino, D Kim, S Pané, SD Santos… - Frontiers in …, 2019 - frontiersin.org
The development of implantable neuroelectrodes is advancing rapidly as these tools are
becoming increasingly ubiquitous in clinical practice, especially for the treatment of …

[HTML][HTML] Astrocytogenesis: where, when, and how

ES Akdemir, AYS Huang, B Deneen - F1000Research, 2020 - ncbi.nlm.nih.gov
Astrocytes are the most abundant cell type in the central nervous system and have diverse
functions in blood–brain barrier maintenance, neural circuitry formation and function, and …

Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease

R Balez, N Steiner, M Engel, SS Muñoz, JS Lum… - Scientific reports, 2016 - nature.com
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases, yet
current therapeutic treatments are inadequate due to a complex disease pathogenesis. The …

Natural variation in gene expression and viral susceptibility revealed by neural progenitor cell villages

MF Wells, J Nemesh, S Ghosh, JM Mitchell, MR Salick… - Cell Stem Cell, 2023 - cell.com
Human genome variation contributes to diversity in neurodevelopmental outcomes and
vulnerabilities; recognizing the underlying molecular and cellular mechanisms will require …

Mimicking human pathophysiology in organ‐on‐chip devices

O Yesil‐Celiktas, S Hassan, AK Miri… - Advanced …, 2018 - Wiley Online Library
Convergence of life sciences, engineering, and basic sciences has opened new horizons for
biologically inspired innovations, and a considerable number of organ‐on‐a‐chip platforms …

Impairments in motor neurons, interneurons and astrocytes contribute to hyperexcitability in ALS: underlying mechanisms and paths to therapy

D Do-Ha, Y Buskila, L Ooi - Molecular neurobiology, 2018 - Springer
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterised by
the loss of motor neurons leading to progressive paralysis and death. Using transcranial …

Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching defects

L Borgs, E Peyre, P Alix, K Hanon, B Grobarczyk… - Scientific reports, 2016 - nature.com
Some mutations of the LRRK2 gene underlie autosomal dominant form of Parkinson's
disease (PD). The G2019S is a common mutation that accounts for about 2% of PD cases …

A simple differentiation protocol for generation of induced pluripotent stem cell-derived basal forebrain-like cholinergic neurons for Alzheimer's disease and …

SS Muñoz, M Engel, R Balez, D Do-Ha… - Cells, 2020 - mdpi.com
The study of neurodegenerative diseases using pluripotent stem cells requires new methods
to assess neurodevelopment and neurodegeneration of specific neuronal subtypes. The …

Using patient-derived induced pluripotent stem cells to identify Parkinson's disease-relevant phenotypes

SL Sison, SC Vermilyea, ME Emborg… - Current neurology and …, 2018 - Springer
Abstract Purpose of Review Parkinson's disease (PD) is the second most common
neurodegenerative disorder affecting older individuals. The specific cause underlying …

Photobiomodulation with a 660-nanometer light-emitting diode promotes cell proliferation in astrocyte culture

SR Yoon, N Hong, MY Lee, JC Ahn - Cells, 2021 - mdpi.com
Astrocytes act as neural stem cells (NSCs) that have the potential to self-renew and
differentiate into other neuronal cells. The protein expression of these astrocytes depends …